miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Authors:
- Enrica CaluraECEnrica Calura
- Robert FruscioRFRobert Fruscio
- Lara ParacchiniLPLara Paracchini
- Eliana BignottiEBEliana Bignotti
- Antonella RavaggiARAntonella Ravaggi
- Paolo MartiniPMPaolo Martini
- Gabriele SalesGSGabriele Sales
- Luca BeltrameLBLuca Beltrame
- Luca ClivioLCLuca Clivio
- Lorenzo CeppiLCLorenzo Ceppi
- Mariacristina Di MarinoMMMariacristina Di Marino
- Ilaria Fuso NeriniINIlaria Fuso Nerini
Open Access
- 31 July 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 19 (15) , 4114-4123
Abstract
Purpose: Epithelial ovarian cancer (EOC) is one of the most lethal gynecologic diseases, with survival rate virtually unchanged for the past 30 years. EOC comprises different histotypes with molecular and clinical heterogeneity, but up till now the present gold standard platinum-based treatment has been conducted without any patient stratification. The aim of the present study is to generate microRNA (miRNA) profiles characteristic of each stage I EOC histotype, to identify subtype-specific biomarkers to improve our understanding underlying the tumor mechanisms. Experimental Design: A collection of 257 snap-frozen stage I EOC tumor biopsies was gathered together from three tumor tissue collections and stratified into independent training (n = 183) and validation sets (n = 74). Microarray and quantitative real-time PCR (qRT-PCR) were used to generate and validate the histotype-specific markers. A novel dedicated resampling inferential strategy was developed and applied to identify the highest reproducible results. mRNA and miRNA profiles were integrated to identify novel regulatory circuits. Results: Robust miRNA markers for clear cell and mucinous histotypes were found. Specifically, the clear cell histotype is characterized by a five-fold (log scale) higher expression of miR-30a and miR-30a*, whereas mucinous histotype has five-fold (log scale) higher levels of miR-192/194. Furthermore, a mucinous-specific regulatory loop involving miR-192/194 cluster and a differential regulation of E2F3 in clear cell histotype were identified. Conclusions: Our findings showed that stage I EOC histotypes have their own characteristic miRNA expression and specific regulatory circuits. Clin Cancer Res; 19(15); 4114–23. ©2013 AACR.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- MMS19 Assembles Iron-Sulfur Proteins Required for DNA Metabolism and Genomic IntegrityScience, 2012
- MAGIA2: from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update)Nucleic Acids Research, 2012
- MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cellsNucleic Acids Research, 2011
- RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentCancer Cell, 2010
- miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in MiceHepatology, 2010
- MAGIA, a web-based tool for miRNA and Genes Integrated AnalysisNucleic Acids Research, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA CircuitClinical Cancer Research, 2008
- Analysis of Gene Expression in Early-Stage Ovarian CancerClinical Cancer Research, 2008
- Prognostic factors for high‐risk early‐stage epithelial ovarian cancerCancer, 2008